- Home
- KNSA vs CLBT Comparison
KNSA vs CLBT Comparison
Compare KNSA & CLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | CLBT |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United Kingdom | Israel |
| Employees | N/A | 1285 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | KNSA | CLBT |
|---|---|---|
| Price | $46.96 | $11.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $55.29 | $22.50 |
| AVG Volume (30 Days) | 565.9K | ★ 1.5M |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $38.01 | $21.45 |
| Revenue Next Year | $17.42 | $17.47 |
| P/E Ratio | $63.27 | ★ $45.29 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $19.42 | $11.76 |
| 52 Week High | $50.03 | $20.53 |
Technical Indicators
Market Signals| Indicator | KNSA | CLBT |
|---|---|---|
| Relative Strength Index (RSI) | 51.17 | 27.95 |
| Support Level | $39.96 | N/A |
| Resistance Level | $48.14 | $15.17 |
| Average True Range (ATR) | 1.83 | 0.75 |
| MACD | -0.03 | -0.22 |
| Stochastic Oscillator | 45.20 | 3.44 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About CLBT Cellebrite DI Ltd.
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.